• HOBt Workflows for Reliable Amide Synthesis

  2026-10-01

  HOBt supports mild, stereochemically conscious amide bond formation across peptide synthesis and medicinal chemistry. This guide translates its activation chemistry into practical workflows, hydration-aware setup, troubleshooting, and a small-molecule case study involving indazole glucagon receptor antagonists.

• Tacalcitol monohydrate: Applied Research Workflows

  2026-10-01

  Tacalcitol monohydrate supports two differentiated workflows: precise induction of nerve growth factor in keratinocytes and VDR-centered sensitization of colorectal cancer cells to 5-fluorouracil. This guide translates those use cases into practical dosing, controls, readouts, troubleshooting steps, and a careful multi-omics lesson from an unrelated thrombosis study.

• Sulfo-NHS-SS-Biotin for Cleavable Labeling

  2026-09-30

  Sulfo-NHS-SS-Biotin combines aqueous amine reactivity with a reducible disulfide spacer, making it useful for surface-restricted labeling, reversible enrichment, and protein purification. This article translates its chemistry into practical workflows and shows how it could complement Epac1–VEGFR2 studies in ischemic retinopathy.

• Ziprasidone HCl: From Receptor Biology to GOT1

  2026-09-30

  Ziprasidone HCl offers a distinctive translational bridge between established receptor pharmacology and emerging GOT1-directed oncology research. This article examines mechanism, exposure, formulation, validation strategy, and the evidence boundaries that should guide serious preclinical programs.

• T0070907: Selective PPARγ Antagonist

  2026-09-29

  T0070907 is a selective PPARγ antagonist with reported 1 nM IC50 and Ki values. It is used to interrogate PPARγ signaling, adipogenesis inhibition, transcriptional coregulator exchange, and cell-cycle responses in cellular research.

• Recombinant Human FGF-19: Practical Assay Guide

  2026-09-29

  This guide explains how to reconstitute, qualify, and apply Recombinant Human FGF-19 in FGFR4 binding, cell proliferation, and metabolic regulation research. It is appropriate for controlled in vitro workflows, but the dossier-based activity data should not be interpreted as evidence of clinical efficacy, therapeutic performance, or universal activity across cell types.

• Potato Virus X for RNA Gene Delivery

  2026-09-28

  The reference study develops potato virus X coat protein as a programmable nucleoprotein platform for delivering custom mRNA and circular RNA. Its central advance is the demonstration of self-assembled, length-controlled, and mixed-composition particles that transfect eukaryotic cells and support reporter-protein expression, while also defining important questions for future validation.

• Z-VAD-FMK for Apoptosis and Host-Cell Assays

  2026-09-28

  Use Z-VAD-FMK to test whether a phenotype depends on caspase signaling—not as a stand-alone proof of apoptosis or cell survival. This guide turns that distinction into a practical workflow for immune-cell and host–pathogen studies, including experiments inspired by recent Toxoplasma virulence research.

• Annexin V-PE in Inflammatory Cell-Fate Studies

  2026-09-27

  The Annexin V-PE Apoptosis Detection Kit can add a cell-fate readout to studies of inflammatory signaling. This article explains how to interpret phosphatidylserine staining alongside the monocyte findings in preterm-infant sepsis research—and where the assay’s limits matter.

• Cy3 Goat Anti-Mouse IgG (H+L) Antibody Guide

  2026-09-26

  This Cy3-conjugated secondary antibody detects mouse primary antibodies in immunofluorescence, flow cytometry, and fluorescent western blot workflows. It is intended for research use only—not diagnostic or medical use—and should not be assumed suitable for live-cell functional assays without checking the sodium azide-containing formulation.

• Danazol Workflows for HPG-Axis Research

  2026-09-25

  Use Danazol to build mechanistically informed endocrine assays—from LH-stimulated steroidogenesis measurements to carefully controlled puberty-model studies. A recent rat study also offers a useful framework for testing interventions against Danazol- and diet-associated HPG-axis changes, while highlighting why model-specific controls matter.

• EdU Imaging Kits for RCC Proliferation Studies

  2026-09-25

  Track S-phase entry while testing how gingerenone A and sunitinib affect renal cancer cells. EdU imaging adds a direct DNA-synthesis readout alongside metabolic and viability assays, helping distinguish reduced proliferation from changes in glycolysis alone.

• FH1 Small Molecule for iHep Maturation

  2026-09-24

  FH1 supports iPS-derived hepatocyte-like cell maturation, with reported gains in albumin secretion and CYP3A4 alongside reduced AFP. This practical guide shows how to build a controlled FH1 workflow, interpret multiple maturity readouts, and keep emerging gene-control applications within the evidence.

• 5-Aminolevulinic acid HCl: Assay Guide

  2026-09-24

  A scenario-based guide to using 5-Aminolevulinic acid HCl (SKU B2070) in cell-based and heme-pathway research, with practical controls for viability, proliferation, and photodynamic workflows. It distinguishes product specifications from study-specific findings and explains how to interpret results without overextending the evidence.

• Exercise Limitation Before Muscle Dysfunction in PH

  2026-09-23

  In two rat models of pulmonary hypertension, reduced exercise capacity was evident alongside right ventricular dysfunction before intrinsic skeletal muscle functional deficits were detected. The comparison across strains and disease severity suggests that cardiopulmonary impairment can limit exercise early, while muscle atrophy may emerge in more severe disease.

8523 records 1/569 page Next 12345 下5页 Last page